Damon Runyon Cancer Research Foundation and St. Jude Children’s Research Hospital award 2026 fellowships
Grant and Award Announcement
Updates every hour. Last Updated: 22-Jun-2026 19:15 ET (22-Jun-2026 23:15 GMT/UTC)
New research from Boston Children’s Hospital, published in Cell, finds that the brain’s resident immune cells, microglia, amass mutations in specific cancer-driving genes yet they don’t manifest as cancer. Instead, these mutations may help drive Alzheimer’s disease. These findings may provide insights into new Alzheimer’s disease diagnostics and treatments.
Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more likely to die of myocarditis, and myocarditis-specific fatality was more common in patients who experienced co-occurring myositis and myasthenia gravis, according to results from a study presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17-22.
Precancerous oral lesions can progress to oral cancer and are typically ablated or surgically removed as a preventive measure
Direct injection of nivolumab immunotherapy into lesions reduced toxicities and reduced lesion size by an average of 60%, decreasing the risk of cancer progression
More than 80% of treated lesions were cancer-free after one year, and patients reported improved quality of life and tolerable side effects
Direct injection approach offers benefits over systemic nivolumab, which could bring excessive toxicities for patients without cancer
Researchers at Tulane University School of Medicine have discovered that if animal cells gain an extra set of chromosomes, a condition known as polyploidy, they activate a stress signaling pathway that causes them to become more mobile and capable of engulfing neighboring cells with normal chromosome numbers. The study, to be published April 21 in the Journal of Cell Biology (JCB), could provide new ways to target polyploid cancer cells, which are thought to promote tumor aggressiveness and therapy resistance.
Glioblastoma, the most common and most aggressive brain tumor type in adults, remains difficult to treat because it can infiltrate surrounding brain tissue and spread far beyond the main tumor. DZNE scientists and collaborators have captured this infiltration process in the living brain with advanced microscopy. Their study, published Immunity, is based on observations in mice affected by a brain cancer very similar to human glioblastoma.